# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-037674
Filing Date
2021-11-12
Accepted
2021-11-12 16:55:33
Documents
74
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | brhc10030504_10q.htm iXBRL | 10-Q | 1693338
2 | EXHIBIT 10.4(B) | brhc10030504_ex10-4b.htm | EX-10.4(B) | 7970
3 | EXHIBIT 31.1 | brhc10030504_ex31-1.htm | EX-31.1 | 7088
4 | EXHIBIT 31.2 | brhc10030504_ex31-2.htm | EX-31.2 | 6902
5 | EXHIBIT 32.1 | brhc10030504_ex32-1.htm | EX-32.1 | 3957
6 | EXHIBIT 32.2 | brhc10030504_ex32-2.htm | EX-32.2 | 4059
12 |  | image00001.jpg | GRAPHIC | 4416
| Complete submission text file | 0001140361-21-037674.txt |  | 7510216

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | btx-20210930.xsd | EX-101.SCH | 72823
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | btx-20210930_cal.xml | EX-101.CAL | 60898
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | btx-20210930_def.xml | EX-101.DEF | 323143
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | btx-20210930_lab.xml | EX-101.LAB | 822045
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | btx-20210930_pre.xml | EX-101.PRE | 475838
13 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc10030504_10q_htm.xml | XML | 1010946

Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-11460 | Film No.: 211404535
SIC: 2834 Pharmaceutical Preparations